Hsbc Holdings PLC Gossamer Bio, Inc. Transaction History

Hsbc Holdings PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$8.63 - $10.94 $103,879 - $131,684	-12,037 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$8.3 - $13.59 $99,907 - $163,582	12,037 New	12,037 $116,000
Q3 2020 Nov 12, 2020	SELL	$11.3 - $14.75 $118,627 - $154,845	-10,498 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.52 - $15.98 $99,940 - $167,758	10,498 New	10,498 $136,000
Q4 2019 Feb 14, 2020	SELL	$14.82 - $26.79 $314,821 - $569,099	-21,243 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$16.02 - $22.47 $340,312 - $477,330	21,243 New	21,243 $357,000

116

163M

821K

557K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $123M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.